Clinical Trials Browser

INDUSTRY × Temozolomide × Dermatologic × Clear all

Advanced Melanoma

NCT06346067 2026-02-27

A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)

Phase 3 Active not recruiting

78 enrolled

Dermatologic

Melanoma

NCT04478279 2026-02-09

A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors

Phase 1/2 Active not recruiting

125 enrolled

BreastCNSDermatologicGenitourinary

Brain Neoplasms, Breast Neoplasms, Glioblastoma, Melanoma, Prostatic Neoplasms

NCT06624644 2025-09-10

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

Phase 2/3 Recruiting

135 enrolled

Dermatologic

Melanoma

NCT05647954 2022-12-13

A Study of HX008 Plus Transcatheter Arterial Chemoembolization (TACE) in the First-Line Treatment of Subjects With Stage IV (M1c) Melanoma That is Metastatic to the Liver

Phase 3 Unknown

350 enrolled

DermatologicEndocrineNET

Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms

NCT02288897 2022-01-19

PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma

Phase 3 Terminated

20 enrolled 13 charts

Dermatologic

Melanoma, Recurrence

NCT01704287 2020-05-18

KEYNOTE 002

Phase 2 Completed

540 enrolled 20 charts

Dermatologic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Melanoma

NCT00804908 2018-06-06

A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic Melanoma

Phase 2 Completed

346 enrolled 15 charts

Dermatologic

Melanoma, Skin Neoplasms

NCT00526617 2017-11-21

A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients

Phase 1 Completed

41 enrolled

BreastDermatologicGastrointestinalGynecologic

Breast Neoplasms, Fallopian Tube Neoplasms, Carcinoma, Hepatocellular, Melanoma, Ovarian Neoplasms

NCT00091572 2017-06-06

Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma (Study P03267)

Phase 3 Completed

859 enrolled 11 charts

Dermatologic

Melanoma

NCT00831545 2017-05-09

Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064)

Phase 2 Completed

162 enrolled

BreastDermatologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma

NCT00724841 2016-07-22

A Phase I/II Study of GMX1777 in Combination With Temozolomide for the Treatment of Metastatic Melanoma

Phase 1/2 Terminated

1 enrolled

Dermatologic

Melanoma

NCT00338130 2014-08-13

Randomised Study to Compare the Efficacy of AZD6244 vs TMZ

Phase 2 Completed

239 enrolled

Dermatologic

Melanoma

NCT01294735 2012-08-15

Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)

Phase 1 Completed

19 enrolled

CNSDermatologic

Glioblastoma, Melanoma

NCT00257205 2012-07-02

CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy

Phase 3 Completed

655 enrolled

Dermatologic

Melanoma

NCT00409383 2011-11-07

Abraxane and Temodar Plus Genasense in Advanced Melanoma

Phase 1 Unknown

28 enrolled

Dermatologic

Melanoma

NCT00609011 2010-08-23

Phase 1 Study of MPC-6827 and Temozolomide in Metastatic Melanoma

Phase 1/2 Completed

22 enrolled

Dermatologic

Melanoma, Neoplasm Metastasis

NCT00991250 2010-02-05

SentoClone® Compared to Reference Treatment in Advanced Malignant Melanoma

Phase 2 Unknown

140 enrolled

Dermatologic

Melanoma

NCT00383851 2007-12-06

Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma

Phase 2 Unknown

60 enrolled

Dermatologic

Melanoma

Clinical Trials

A Phase II Trial of LM103 in Advanced Melanoma

A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)

A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

A Study of HX008 Plus Transcatheter Arterial Chemoembolization (TACE) in the First-Line Treatment of Subjects With Stage IV (M1c) Melanoma That is Metastatic to the Liver

PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma

KEYNOTE 002

A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic Melanoma

A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients

Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma (Study P03267)

Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064)

A Phase I/II Study of GMX1777 in Combination With Temozolomide for the Treatment of Metastatic Melanoma

Randomised Study to Compare the Efficacy of AZD6244 vs TMZ

Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)

CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy

Abraxane and Temodar Plus Genasense in Advanced Melanoma

Phase 1 Study of MPC-6827 and Temozolomide in Metastatic Melanoma

SentoClone® Compared to Reference Treatment in Advanced Malignant Melanoma

Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma